Journal Title：Expert Opinion On Drug Discovery

Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.

The Editors welcome:

Reviews covering chemoinformatics; bioinformatics; assay development; novel screening technologies; in vitro/in vivo models; structure-based drug design; systems biology

Drug Case Histories examining the steps involved in the preclinical and clinical development of a particular drug

The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimisation at the preclinical level.

《藥物發(fā)現(xiàn)專家意見》（ISSN 1746-0441 [印刷版]，1746-045X [電子版]）是一本 MEDLINE 索引、同行評(píng)審的國際期刊，發(fā)表有關(guān)藥物發(fā)現(xiàn)過程中涉及的新技術(shù)的評(píng)論文章，從而帶來新的線索并降低流失率。每篇文章都包含作者自己對(duì)未來發(fā)展范圍的專家意見。

編輯歡迎：

評(píng)論涵蓋化學(xué)信息學(xué)；生物信息學(xué)；檢測(cè)開發(fā)；新型篩選技術(shù)；體外/體內(nèi)模型；基于結(jié)構(gòu)的藥物設(shè)計(jì)；系統(tǒng)生物學(xué)

藥物案例歷史，研究特定藥物的臨床前和臨床開發(fā)所涉及的步驟

讀者包括醫(yī)療保健和制藥行業(yè)的科學(xué)家和管理人員、學(xué)術(shù)制藥科學(xué)家和其他密切相關(guān)的專業(yè)人士，他們希望通過臨床前水平的優(yōu)化來提高其候選藥物的成功率。

Expert Opinion On Drug Discovery創(chuàng)刊于2006年，由Informa Healthcare出版商出版，收稿方向涵蓋醫(yī)學(xué) - 藥學(xué)全領(lǐng)域，此刊是該細(xì)分領(lǐng)域中屬于非常不錯(cuò)的SCI期刊，在行業(yè)細(xì)分領(lǐng)域中學(xué)術(shù)影響力較大，專業(yè)度認(rèn)可很高，所以對(duì)原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 較慢,6-12周 ，影響因子指數(shù)6，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。